- Investing Ideas
- Danish Pharmaceuticals & Biotech High Insider Buying
Danish Pharmaceuticals & Biotech High Insider Buying
Results
4
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
4 companies
H. Lundbeck
Market Cap: DKK 37.0b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 38.66
7D
3.4%
1Y
11.4%
Bavarian Nordic
Market Cap: DKK 14.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 191.00
7D
0.4%
1Y
20.2%
Gubra
Market Cap: DKK 5.8b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 355.40
7D
-4.0%
1Y
-14.2%
ChemoMetec
Market Cap: DKK 5.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 290.00
7D
-27.2%
1Y
-43.1%